Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib extension trial in cancer patients
NCT00635973Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gefitinib in cancer, sponsored by AstraZeneca. Started Feb 2000; status: completed.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00635973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635973.